Back to Search
CHRISTINA KAUL, M.D.
Infectious Disease Physician
NPI: 1194187724IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
298916(NY)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
298916(NY)
Education
BAYLOR COLLEGE OF MEDICINE
Class of 2016
Research & Publications (20)
Subjective experience of motion or attentional selection of a categorical decision.
PMID 18417689·J Neurosci·2008
6-review
Programmable self-assembly of metal ions inside artificial DNA duplexes.
PMID 18654185·Nat Nanotechnol·2006
8-other
Effect of tempol on altered angiotensin II and acetylcholine-mediated vascular responses in thoracic aorta isolated from rats with insulin resistance.
PMID 16412660·Pharmacol Res·2006
4-observational
A study on alpha-adrenoceptor mediated contractile responses of high fat diet fed rat thoracic aorta.
PMID 15739905·Pharmazie·2005
7-preclinical
Establishment of a reference formulation for bioequivalence assessment of rifampicin-containing FDCs: an essential step towards improving tuberculosis treatment.
PMID 16013776·Int J Tuberc Lung Dis·2005
3-trial
Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.
PMID 15979893·Pharmacol Res·2005
7-preclinical
AT1 receptors and L-type calcium channels: functional coupling in supersensitivity to angiotensin II in diabetic rats.
PMID 15639476·Cardiovasc Res·2005
7-preclinical
Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux.
PMID 16398269·Pharmazie·2005
7-preclinical
Quality control of anti-tuberculosis FDC formulations in the global market: part II-accelerated stability studies.
PMID 16333936·Int J Tuberc Lung Dis·2005
8-other
Determination of rifampicin bioequivalence in a three-drug FDC by WHO and indian protocols: effect of sampling schedule and size.
PMID 15675554·Int J Tuberc Lung Dis·2005
3-trial
Effects of adenosine and adenosine A2A receptor agonist on motor nerve conduction velocity and nerve blood flow in experimental diabetic neuropathy.
PMID 15829161·Neurol Res·2005
4-observational
Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
PMID 15519530·Pharmacol Res·2005
6-review
Plasma pooling: utility in expediting bioequivalence assessment of rifampicin-containing fixed-dose combinations.
PMID 15971401·Int J Tuberc Lung Dis·2005
8-other
Minimum sample size and sampling time requirements for assessment of rifampicin bioequivalence from FDC formulations.
PMID 16333937·Int J Tuberc Lung Dis·2005
8-other
Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats.
PMID 15848214·Life Sci·2005
7-preclinical
Discovery of a bulky 2-tert-butyl group containing primaquine analogue that exhibits potent blood-schizontocidal antimalarial activities and complete elimination of methemoglobin toxicity.
PMID 14711300·J Med Chem·2004
7-preclinical
8-Quinolinamines conjugated with amino acids are exhibiting potent blood-schizontocidal antimalarial activities.
PMID 14697789·Bioorg Med Chem·2004
4-observational
Neuroprotective effect of peroxynitrite decomposition catalyst and poly(adenosine diphosphate-ribose) polymerase inhibitor alone and in combination in rats with focal cerebral ischemia.
PMID 15481724·J Neurosurg·2004
7-preclinical
Fixed dose combinations for tuberculosis: Lessons learned from clinical, formulation and regulatory perspective.
PMID 15632956·Methods Find Exp Clin Pharmacol·2004
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via INTERNAL MEDICINE SPECIALIST OF NEW YORK P.C · 3 locations total
- Address
- 300 COMMUNITY DR
MANHASSET, NY 11030 - Phone
- (516) 562-0100
Quick Facts
- NPI
- 1194187724
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 3
- Publications
- 20
Are you this provider?
Claim Your Profile